UNSPSC 51293002: Amitriptyline

This classification denotes a tricyclic antidepressant with the molecular formula C20H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1806D8D52K, chemically known as 10,11-dihydro-n,n-dimethyl-5h-dibenzo(a,d)heptalene-delta(sup 5),gamma-propylamine but generally known as amitriptyline, which bears US NIH Compound Identifier 2160. Amitriptyline most often comes in base, chloride, hydrochloride, n-glucuronide, and n-oxide forms.

UNSPSC 51293002 Amitriptyline is a Commodity code that nominally denotes a specific pharmaceutical product, but state and local procurement activity under this code shows a substantial mismatch with the code's named scope. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS — solicits Naloxone and Safe Drug Deactivation Systems, not Amitriptyline. The procurement seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Vendors must submit bids electronically, include all shipping and delivery costs in proposals, maintain drug-free workplace certification and E-Verify compliance, carry workers' compensation and commercial general liability insurance, and accept a three-month probationary termination clause. The initial contract term is two years with an optional one-year renewal, potentially funded through FEMA with attendant federal compliance obligations.

The code shows minimal recent state and local activity and only one documented opportunity in the recent-opportunities block. Geographic activity appears limited to Florida based on the single Seminole County solicitation. The response deadline for the Seminole County IFB was July 26, 2023. Given the mismatch between the code's pharmaceutical name and the actual procurement scope (drug-deactivation and overdose-reversal systems rather than a tricyclic antidepressant), this code appears to be either miscoded in the state and local procurement database or carries a narrower meaning in local systems than its UNSPSC designation suggests. Business development professionals should verify whether similar opportunities under this code actually involve Amitriptyline procurement or if this represents a broader pattern of miscoding across health-related pharmaceutical commodities.